Suchen
Evogene Ltd
EVGNZur Watchlist hinzufügen
0.430USD
-0.011-2.56%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
4.47MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Evogene Ltd Unternehmen
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Evogene Ltd Informationen
BörsenkürzelEVGN
Name des UnternehmensEvogene Ltd
IPO-datumJun 11, 2007
CEOEmber (Brian)
Anzahl der mitarbeiter117
WertpapierartOrdinary Share
GeschäftsjahresendeJun 11
Addresse13 Gad Feinstein Street
StadtREHOVOT
BörseNASDAQ OMX - NASDAQ BASIC
LandIsrael
Postleitzahl7638517
Telefon97289311900
Websitehttps://evogene.com/
BörsenkürzelEVGN
IPO-datumJun 11, 2007
CEOEmber (Brian)
Führungskräfte von Evogene Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Mark Kapel
Mr. Mark Kapel
Executive Vice President - Technology
Executive Vice President - Technology
--
--
Mr. Ziv Kop
Mr. Ziv Kop
Independent Director
Independent Director
--
--
Prof. Adrian Percy
Prof. Adrian Percy
Independent Director
Independent Director
--
--
Dr. Elran Hilel Haber
Dr. Elran Hilel Haber
Chief Executive Officer of Biomica Limited
Chief Executive Officer of Biomica Limited
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Evogene Ltd?
Die fünf größten Anteilseigner von Evogene Ltd sind: Mr. Leon Yehuda Recanati
Wie viele Institutionen halten Anteile an Evogene Ltd (EVGN)?
Mit Stand vom 2026Q1 halten 50 Institutionen Anteile an Evogene Ltd, mit einem Gesamtmarktwert von etwa 201.08K, was 2.31% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -676818.00 gestiegen.